Is RECQL p.Pro191Gln (c.572C>A) pathogenic?

RECQL p.Pro191Gln (c.572C>A) is classified Uncertain significance in RECQL (ClinVar, No assertion criteria, 1 submitter). AlphaMissense: likely pathogenic (0.9966); Absent from gnomAD v4.1; Associated with hepatoblastoma.

What condition is associated with RECQL p.Pro191Gln (c.572C>A)?

RECQL p.Pro191Gln (c.572C>A) is associated with hepatoblastoma (ClinVar).

How common is RECQL p.Pro191Gln (c.572C>A) in the general population?

RECQL p.Pro191Gln (c.572C>A) is absent from gnomAD v4.1 (gnomAD).

How is Hepatoblastoma inherited?

Typically Not applicable (Orphanet). A genetic counselor can assess individual risk for a family.

What do computational predictors say about RECQL p.Pro191Gln (c.572C>A)?

AlphaMissense predicts likely pathogenic (score 0.9966) — an in-silico prediction, not a clinical call.

RECQL p.Pro191Gln

c.572C>A · rs2137374485 · VCV1343306

Uncertain significance No assertion criteria

Classification

Uncertain significance

ClinVar

Review

No assertion criteria ☆☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely pathogenic

0.9966 · ACMG-weighted

gnomAD v4.1

Absent

absent from gnomAD v4.1

Missense predictors

2/2 damaging

AlphaMissense, SaProt · REVEL indeterminate

Conditions

hepatoblastoma

Computational evidence

Protein change
AlphaMissense	0.9966	likely pathogenic · top 2% in RECQL
REVEL	0.614	indeterminate
SaProt	LLR -16.17	damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 12	GERP 1.5, phastCons 1
Regional constraint	o/e 0.94	unconstrained · MANE · 29 kb · p 0.095 · regional, not allelic
Overall
CADD	29.8	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Variant & gene context

Gene: RECQL
Protein: p.Pro191Gln
Coding: c.572C>A
MANE Select: NM_002907
dbSNP: rs2137374485
Type: single nucleotide variant
Location: chr12:21483504 (GRCh38)
Gene constraint: LOEUF 1.235 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure: AlphaFold pLDDT 86.55 · 7 PDB
Residue 191: the helicase atp-binding domain; an α-helix

Full RECQL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hepatoblastoma — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Hepatoblastoma (Orphanet):

Inheritance: Not applicable
Onset: Childhood, Infancy, Neonatal
Prevalence: <1 / 1 000 000 (Europe)

Similar variants

RECQL p.Pro191= Likely benign ★★ same residue
RECQL p.Pro191Ala Uncertain significance ★ ⚠ same residue
RECQL p.Pro191Thr Uncertain significance ★ ⚠ same residue
RECQL c.1098+1G>A Uncertain significance ★★ same type
RECQL c.1216+3A>G Uncertain significance ★★ same type
RECQL c.1217-3C>T Uncertain significance ★★ same type
RECQL c.1355+1G>A Uncertain significance ★★ same type
RECQL c.1356-12A>G Uncertain significance ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/recql-p-pro191gln (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown